This study is accepting new patients by invitation only
Safety, Tolerability and Efficacy of ICV AX 250 Treatment in MPS IIIB -OLE
Summary
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Allievex Corporation
- ID
- NCT05492799
- Phase
- Phase 4 research study
- Study Type
- Interventional
- Participants
- Expecting 15 study participants
- Last Updated